½ÃÀ庸°í¼­
»óǰÄÚµå
1671833

¿¢¼ÒÁ» ½ÃÀå : Á¦Ç° ¹× ¼­ºñ½ºº°, ÀûÀÀÁõº°, ¿ëµµº°, Á¦Á¶ ¼­ºñ½ºº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°

Exosomes Market, By Product & Service, By Indication, By Application, By Manufacturing Service, By End User, By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ¿¢¼ÒÁ» ½ÃÀåÀº 2025³â¿¡ 2¾ï 2,210¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2032³â¿¡´Â 12¾ï 8,410¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025-2032³â ¿¬Æò±Õ 28.5%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ »ó¼¼ ³»¿ë
±âÁØ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 2¾ï 2,210¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£ : 2025-2032³â CAGR: 28.50% 2032³â °¡Ä¡ ¿¹Ãø 12¾ï 8,410¸¸ ´Þ·¯
±×¸². 2025³â Áö¿ªº° ¿¢¼ÒÁ» ½ÃÀå Á¡À¯À²(%), Áö¿ªº°, 2025³â
Exosomes Market-IMG1

¿¢¼ÒÁ»Àº ´Ü¹éÁú, ÁöÁú, À¯Àü¹°ÁúÀ» ¼¼Æ÷ °£¿¡ Àü´ÞÇÏ´Â ¼¼Æ÷ °£ ¸Þ½ÅÀú ¿ªÇÒÀ» ÇÏ´Â ³ª³ë Å©±âÀÇ ¼¼Æ÷¿Ü ¼ÒÆ÷·Î, ¼¼Æ÷ °£ Àü´ÞÀÚ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¿¢¼ÒÁ»Àº ´Ù¾çÇÑ À¯ÇüÀÇ ¼¼Æ÷¿¡¼­ ÀÚ¿¬ÀûÀ¸·Î ¹æÃâµÇ¸ç, ¼÷ÁÖ¼¼Æ÷¸¦ ¹Ý¿µÇϴ ƯÁ¤ »ýü ºÐÀÚ¸¦ ¿î¹ÝÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ´É·ÂÀ¸·Î ÀÎÇØ ¿¢¼ÒÁ»Àº Á¾¾çÇÐ, ½Å°æÇÐ, ¼øÈ¯±âÇÐ µî ´Ù¾çÇÑ ¿ëµµ¿¡¼­ ÀáÀçÀûÀÎ Áø´Ü ¹× Ä¡·á Åø·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. º¹ÀâÇÑ Áúº´¿¡ ´ëÇÑ ¿¢¼ÒÁ» ±â¹Ý Ä¡·á ¹× Áø´ÜÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ¿¹Ãø ±â°£ Áß ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÃÀå ¿ªÇÐ:

¼¼°è ¿¢¼ÒÁ» ½ÃÀåÀÇ ¼ºÀåÀº ¿¢¼ÒÁ» °úÇп¡ ´ëÇÑ ¿¬±¸ ÀÚ±Ý Áõ°¡, Áúº´ °ü¸®¿¡ ´ëÇÑ ¿¢¼ÒÁ»ÀÇ ÀÓ»ó Àû¿ë Áõ°¡, ¿¢¼ÒÁ»ÀÇ ÀÌÁ¡À» Ȱ¿ëÇÏ·Á´Â Á¦¾àȸ»çÀÇ °ü½É Áõ°¡ µîÀÇ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ±×·¯³ª ¿¢¼ÒÁ» ºÐ¸® ¹× Ư¼º ºÐ¼® ±â¼úÀÇ ±â¼úÀû °úÁ¦, ¿¢¼ÒÁ»À» ÀÌ¿ëÇÑ Ä¡·á¿Í °ü·ÃµÈ ³ôÀº ºñ¿ë µîÀÇ ¿äÀÎÀÌ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù. ¶ÇÇÑ ¿¢¼ÒÁ» ±â¹ÝÀÇ »õ·Î¿î Ä¡·á¹ý ¹ß°ß°ú ¾à¹°Àü´Þ¿¡ ¿¢¼ÒÁ»À» Ȱ¿ëÇÏ´Â µî ÇöÀç Á÷¸éÇÑ ¹®Á¦¸¦ ±Øº¹ÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ´Â ºÐ¾ßÀÇ ±âȸµµ Á¸ÀçÇÕ´Ï´Ù. ¶ÇÇÑ ¹é½Å °³¹ß¿¡¼­ ¿¢¼ÒÁ» ÀÀ¿ë¿¡ ´ëÇÑ °ü½ÉÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¿¹Ãø ±â°£ Áß »õ·Î¿î ±æÀÌ ¿­¸± °ÍÀÔ´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

¼¼°èÀÇ ¿¢¼ÒÁ»(Exosome) ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇÏ¿© 2024³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2025-2032³â) ½ÃÀå ±Ô¸ð¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» Á¶»ç ºÐ¼®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¸ÅÃâ ±âȸ¸¦ ÆÄ¾ÇÇϰí ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.

¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ ÁÖ¿ä ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.

ÀÌ º¸°í¼­´Â ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, ¼º°ú, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è ¿¢¼Ø ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.

ÁÖ¿ä ±â¾÷¿¡´Â Thermo Fisher Scientific, Inc., Bio-Techne, QIAGEN, Lonza, System Biosciences, LLC, Miltenyi Biotech, NX Pharmagen, Aethlon Medical, Inc., Creative Medical Technologies Holdings, Inc., Exopharm, RoosterBio, Inc., Danaher Corporation, Everzom, Ciloa, Unchained Labs µîÀÌ ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ­, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü·«¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.

¼¼°è ¿¢¼ÒÁ» ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µî ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è ¿¢¼ÒÁ» ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ÀüÁ¦Á¶°Ç
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • ¸®Æ÷Æ® ¼³¸í
    • ½ÃÀåÀÇ Á¤ÀÇ¿Í ¹üÀ§
  • °³¿ä

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
  • ¿µÇ⠺м®
  • ÁÖ¿ä ¹ßÀü
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Á¦Ç°ÀÇ ¹ß¸Å/½ÂÀÎ
  • PEST ºÐ¼®
  • PORTERÀÇ »ê¾÷ ºÐ¼®
  • ÇÕº´°ú Àμö ½Ã³ª¸®¿À
  • ¾÷°è µ¿Çâ

Á¦4Àå ¼¼°èÀÇ ¿¢¼ÒÁ» ½ÃÀå, Á¦Ç°¡¤¼­ºñ½ºº°, 2020-2032³â, (100¸¸ ´Þ·¯)

  • ŰƮ¿Í ½Ã¾à
  • Ç×ü
  • ºÐ¸®, Á¤Á¦, Á¤·® ŰƮ
  • ±âŸ ŰƮ¿Í ½Ã¾à
  • ±â±â
  • ¼­ºñ½º

Á¦5Àå ¼¼°èÀÇ ¿¢¼ÒÁ» ½ÃÀå, ÀûÀÀÁõº°, 2020-2032³â, (100¸¸ ´Þ·¯)

  • ¾Ï
  • ½Å°æº¯¼ºÁúȯ
  • ½ÉÇ÷°üÁúȯ
  • °¨¿°Áõ
  • ±âŸ Áúº´

Á¦6Àå ¼¼°èÀÇ ¿¢¼ÒÁ» ½ÃÀå, ¿ëµµº°, 2020-2032³â, (100¸¸ ´Þ·¯)

  • ¹ÙÀÌ¿À¸¶Ä¿
  • ¹é½Å °³¹ß
  • Á¶Á÷ Àç»ý
  • ¾à¹°Àü´Þ
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ ¿¢¼ÒÁ» ½ÃÀå, Á¦Á¶ ¼­ºñ½ºº°, 2020-2032³â, (100¸¸ ´Þ·¯)

  • Áٱ⼼Æ÷ À¯·¡ ¿¢¼ÒÁ»
  • ¼ö»ó¼¼Æ÷ À¯·¡ ¿¢¼ÒÁ»
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ ¿¢¼ÒÁ» ½ÃÀå, ÃÖÁ¾ ¿ëµµº°, 2020-2032³â, (100¸¸ ´Þ·¯)

  • Çмú Á¶»ç±â°ü
  • Á¦¾à¡¤¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
  • º´¿ø¡¤ÀÓ»ó °Ë»ç½Ç
  • ±âŸ

Á¦9Àå ¼¼°èÀÇ ¿¢¼ÒÁ» ½ÃÀå, Áö¿ªº°, 2020-2032³â, °¡Ä¡(100¸¸ ´Þ·¯)

  • ºÏ¹Ì
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿
  • ¾ÆÇÁ¸®Ä«

Á¦10Àå °æÀï ±¸µµ

  • Thermo Fisher Scientific, Inc.
  • Bio-Techne
  • QIAGEN
  • Lonza
  • System Biosciences, LLC
  • Miltenyi Biotech
  • NX Pharmagen
  • Aethlon Medical, Inc.
  • Creative Medical Technologies Holdings, Inc.
  • Exopharm
  • RoosterBio, Inc.
  • Danaher Corporation
  • Everzom
  • Ciloa
  • Unchained Labs

Á¦11Àå ¾Ö³Î¸®½ºÆ®ÀÇ ±ÇÀå»çÇ×

  • ¿î¸íÀÇ ¼ö·¹¹ÙÄû
  • ¾Ö³Î¸®½ºÆ®ÀÇ °ßÇØ
  • COM(Coherent Opportunity Map)

Á¦12Àå Âü°í ¹®Çå°ú Á¶»ç ¹æ¹ý

  • Âü°í ¹®Çå
  • Á¶»ç ¹æ¹ý
  • ÃâÆÇ»ç ¼Ò°³
KSA 25.03.20

The Global Exosomes Market is estimated to be valued at USD 222.1 Mn in 2025 and is expected to reach USD 1,284.1 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 28.5% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 222.1 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 28.50% 2032 Value Projection: USD 1,284.1 Mn
Figure. Exosomes Market Share (%), By Region, 2025
Exosomes Market - IMG1

Exosomes are nano-sized extracellular vesicles that act as intercellular messengers by transferring proteins, lipids, and genetic materials between cells. They are released naturally by many cell types and carry specific biomolecules reflective of the host cells. Due to this ability, exosomes have emerged as potential diagnostic and therapeutic tools across various application areas such as oncology, neurology, and cardiology. The rising adoption of exosome-based therapies and diagnostics for complex diseases is expected to drive the market growth during the forecast period.

Market Dynamics:

The growth of the global exosomes market is driven by factors such as increasing research funding in exosome science, rising clinical applications of exosomes in disease management, and growing focus of pharmaceutical companies on harnessing exosome benefits. However, factors such as technical challenges in exosome isolation and characterization techniques as well as high costs associated with exosome-based procedures are likely to restrain the market growth. The market also presents opportunities in areas such as discovery of novel exosome-based therapies and use of exosomes for drug delivery that can help in overcoming some of the current challenges. Furthermore, growing interest in exosome applications in vaccine development will open up new avenues during the forecast period.

Key Features of the Study:

This report provides in-depth analysis of the global exosomes market and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global exosomes market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Thermo Fisher Scientific, Inc., Bio-Techne, QIAGEN, Lonza, System Biosciences, LLC, Miltenyi Biotech, NX Pharmagen, Aethlon Medical, Inc., Creative Medical Technologies Holdings, Inc., Exopharm, RoosterBio, Inc., Danaher Corporation, Everzom, Ciloa, and Unchained Labs

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global exosomes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global exosomes market

Market Segmentation

  • By Product & Service Insights (Revenue, USD Mn, 2020 - 2032)
    • Kits & Reagents
    • Antibodies
    • Isolation, Purification, Quantitation Kits
    • Other Kits & Reagents
    • Instruments
    • Services
  • By Indication Insights (Revenue, USD Mn, 2020 - 2032)
    • Cancer
    • Neurodegenerative Diseases
    • Cardiovascular Diseases
    • Infectious Diseases
    • Other Diseases
  • By Application Insights (Revenue, USD Mn, 2020 - 2032)
    • Biomarkers
    • Vaccine Development
    • Tissue Regeneration
    • Drug Delivery
    • Other Applications
  • By Manufacturing Service Insights (Revenue, USD Mn, 2020 - 2032)
    • Stem Cell-Derived Exosome Manufacturing Services
    • Dendritic Cell-Derived Exosome
    • Others
  • By End User Insights (Revenue, USD Mn, 2020 - 2032)
    • Academic & Research Institutes
    • Pharmaceutical & Biotechnology Companies
    • Hospitals & Clinical Laboratories
    • Others
  • Regional Insights (Revenue, USD Mn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Thermo Fisher Scientific, Inc.
    • Bio-Techne
    • QIAGEN
    • Lonza
    • System Biosciences, LLC
    • Miltenyi Biotech
    • NX Pharmagen
    • Aethlon Medical, Inc.
    • Creative Medical Technologies Holdings, Inc.
    • Exopharm
    • RoosterBio, Inc.
    • Danaher Corporation
    • Everzom
    • Ciloa
    • Unchained Labs

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Exosomes Market, By Product & Service
    • Global Exosomes Market, By Indication
    • Global Exosomes Market, By Application
    • Global Exosomes Market, By Manufacturing Service
    • Global Exosomes Market, By End User
    • Global Exosomes Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Driver
    • Restraint
    • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Exosomes Market, By Product & Service, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Kits & Reagents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Antibodies
  • Isolation, Purification, Quantitation Kits
  • Other Kits & Reagents
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Exosomes Market, By Indication, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Neurodegenerative Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Cardiovascular Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Infectious Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Other Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Exosomes Market, By Application, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Biomarkers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Vaccine Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Tissue Regeneration
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Drug Delivery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Other Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Exosomes Market, By Manufacturing Service, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Stem Cell-Derived Exosome Manufacturing Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Dendritic Cell-Derived Exosome
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Exosomes Market, By End User, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Academic & Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Pharmaceutical & Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Hospitals & Clinical Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global Exosomes Market, By Region, 2020 - 2032, Value (USD Mn)

  • Introduction
    • Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Mn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Manufacturing Service, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Manufacturing Service, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Manufacturing Service, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Manufacturing Service, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Manufacturing Service, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Manufacturing Service, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

10. Competitive Landscape

  • Thermo Fisher Scientific, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bio-Techne
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • QIAGEN
  • Lonza
  • System Biosciences, LLC
  • Miltenyi Biotech
  • NX Pharmagen
  • Aethlon Medical, Inc.
  • Creative Medical Technologies Holdings, Inc.
  • Exopharm
  • RoosterBio, Inc.
  • Danaher Corporation
  • Everzom
  • Ciloa
  • Unchained Labs

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦